SI-BONE's iFuse Implant System is now exclusively covered by 23 commercial health plans.
The triangular iFuse Implant System is intended for sacroiliac fusion to treat conditions such sacroiliac joint dysfunction, that are a direct result of sacroiliac joint disruption and degenerative sacroiliitis.
The exclusive positive coverage policies provide access to minimally invasive SI joint fusion with the iFuse Implant System for over 35 million health plan members. Recently, eviCore healthcare published positive recommendation for the use of the iFuse Implant.